We would love to hear your thoughts about our site and services, please take our survey here.
Doberman I’m only guessing but if the £40m is still available and a large income is generated from IP / commissions there will be significant funds available to both research and dividend payments.
My feeling would be much less optimistic than £3 but still nice to look forward to. So if several staff want to hold shares, not just to cash in on the rise and pay 20% cap gains tax, with enough time before a div payment in order to be eligible. That was my joining the dots thought.....of course could be wrong x RB
Dumbpunter
Thanks for the calculation RB
Goldtrig
No angle ;-) I was reading some posts from folk who said they couldn’t understand why the value of Avacta wasn’t better appreciated, my opinion also! I’d already asked and received opinion re RNS. So decided to share as I thought it a good benchmark of folk having a brief look at Avacta compared to watching many, many times daily the ups and downs LTH have lived with.
When my friend and I talked after email reply he thought my investment was safe and stood a good chance for me to make a good profit. That’s all RB x
I asked a friend who was a FD and has taken 4 companies public what he thought of the RNS this week. He doesn’t follow Avacta, so outside eyes and opinion. The reply surprised me as I am very invested and believe we are very near great times.
“ Reads well and is very well funded. But it is still jam tomorrow. Looks like they will get there by the end of the year.”
I guess this is the opinion many, having a quick look, will also have. No real reason to share just found it interesting and thought some of you may too x RB
Just a great listen on Vox link
https://bit.ly/3dJdo98
Total confidence giver to share holders and prospective share holders RB x
Great video of BJ about vaccines and UK science business, naming and praising.
I am quite convinced when enough of the population have been jabbed he will do the same for testing ..... exciting times ahead x RB